| A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity A Banzato, S Bobisse, M Rondina, D Renier, F Bettella, G Esposito, ... Clinical cancer research 14 (11), 3598-3606, 2008 | 129 | 2008 |
| Glutathione transferases as targets for cancer therapy P Ruzza, A Rosato, CR Rossi, M Floreani, L Quintieri Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 116 | 2009 |
| Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes L Quintieri, P Palatini, A Nassi, P Ruzza, M Floreani Biochemical pharmacology 75 (6), 1426-1437, 2008 | 109 | 2008 |
| Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity M Floreani, E Napoli, L Quintieri, P Palatini Life sciences 72 (24), 2741-2750, 2003 | 107 | 2003 |
| Pharmacokinetics of intraperitoneal cisplatin and doxorubicin CR Rossi, S Mocellin, P Pilati, M Foletto, L Quintieri, P Palatini, M Lise Surgical Oncology Clinics 12 (3), 781-794, 2003 | 100 | 2003 |
| Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes L Quintieri, C Geroni, M Fantin, R Battaglia, A Rosato, W Speed, ... Clinical cancer research 11 (4), 1608-1617, 2005 | 76 | 2005 |
| Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs L Quintieri, M Fantin, C Vizier Microarray Technology and Cancer Gene Profiling, 95-104, 2007 | 57 | 2007 |
| Hyperthermic isolated perfusion with low-dose tumor necrosis factor α and doxorubicin for the treatment of limb-threatening soft tissue sarcomas CR Rossi, S Mocellin, P Pilati, M Foletto, L Campana, L Quintieri, ... Annals of surgical oncology 12, 398-405, 2005 | 44 | 2005 |
| Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers F Greco, I Arif, R Botting, C Fante, L Quintieri, C Clementi, O Schiavon, ... Polymer Chemistry 4 (5), 1600-1609, 2013 | 41 | 2013 |
| LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation E Zulato, F Ciccarese, V Agnusdei, M Pinazza, G Nardo, E Iorio, ... Biochemical pharmacology 156, 479-490, 2018 | 40 | 2018 |
| In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A L Quintieri, A Rosato, E Napoli, F Sola, C Geroni, M Floreani, P Zanovello Cancer research 60 (12), 3232-3238, 2000 | 39 | 2000 |
| Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro L Quintieri, S Bortolozzo, S Stragliotto, S Moro, M Pavanetto, A Nassi, ... Drug metabolism and pharmacokinetics 25 (5), 466-476, 2010 | 37 | 2010 |
| Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties M Fantin, L Quintieri, E Kúsz, E Kis, H Glavinas, M Floreani, R Padrini, ... European journal of pharmacology 535 (1-3), 301-309, 2006 | 37 | 2006 |
| Ethylene negatively regulates transcript abundance of ROP-GAP rheostat-encoding genes and affects apoplastic reactive oxygen species homeostasis in epicarps of cold stored … M Zermiani, E Zonin, A Nonis, M Begheldo, L Ceccato, A Vezzaro, ... Journal of Experimental Botany 66 (22), 7255-7270, 2015 | 35 | 2015 |
| Olopatadine: a drug for allergic conjunctivitis targeting the mast cell A Leonardi, L Quintieri Expert Opinion on Pharmacotherapy 11 (6), 969-981, 2010 | 31 | 2010 |
| Vanillin analogues o-vanillin and 2, 4, 6-trihydroxybenzaldehyde inhibit NFĸB activation and suppress growth of A375 human melanoma A Marton, E Kúsz, C Kolozsi, V Tubak, G Zagotto, K Buzás, L Quintieri, ... Anticancer Research 36 (11), 5743-5750, 2016 | 30 | 2016 |
| A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts A De Luca, D Rotili, D Carpanese, A Lenoci, L Calderan, M Scimeca, ... Oncotarget 6 (6), 4126, 2015 | 30 | 2015 |
| Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications L Quintieri, M Selmy, S Indraccolo Biochemical pharmacology 89 (2), 162-170, 2014 | 27 | 2014 |
| Irreversible CYP3A inhibition accompanied by plasma protein–binding displacement: a comparative analysis in subjects with normal and impaired liver function R Orlando, S De Martin, P Pegoraro, L Quintieri, P Palatini Clinical Pharmacology & Therapeutics 85 (3), 319-326, 2009 | 27 | 2009 |
| Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin L Quintieri, P Palatini, S Moro, M Floreani Drug metabolism and pharmacokinetics 26 (6), 559-568, 2011 | 24 | 2011 |
Stefano MoroProfessor of Medicinal ChemistryVerified email at unipd.it
